Evidence map›Paper›PMID 28238201›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2018

Advances in optogenetic and chemogenetic methods to study brain circuits in non-human primates.

Adriana Galvan, Michael J Caiola, Daniel L Albaugh

Abstract readReview
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Parkinsonism Disrupts Neuronal Modulation in the Presupplementary Motor Area during Movement Preparation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Non-human primate models of focal cortical ischemia for neuronal replacement therapy.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Demonstration of an Optimized Large-scale Optogenetic Cortical Interface for Non-human Primates.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2022
    Article
  13. Applications of chemogenetics in non-human primates.Current opinion in pharmacology · 2022
    Review
  14. Article
  15. Review
  16. "Natural Laboratory Complex" for novel primate neuroscience.Frontiers in integrative neuroscience · 2022
    Article
  17. Review
  18. Article
  19. The prefrontal cortex, pathological anxiety, and anxiety disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Adriana GalvanDepartment of Neurology, Yerkes National Primate Research Center, School of Medicine, Emory University, Atlanta, GA, 30329, USA. agalvan@emory.edu.ORCID 0000-0001-9939-0130
Michael J CaiolaDepartment of Neurology, Yerkes National Primate Research Center, School of Medicine, Emory University, Atlanta, GA, 30329, USA.
Daniel L AlbaughDepartment of Neurology, Yerkes National Primate Research Center, School of Medicine, Emory University, Atlanta, GA, 30329, USA.
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Udall Parkinson's Disease Research Center at Emory UniversityP50NS098685 · NINDS · EMORY UNIVERSITY · PI WICHMANN, THOMAS · 2016 to 2020
$6.7M
Thalamic interactions with the striatumR01NS083386 · NINDS · EMORY UNIVERSITY · PI WICHMANN, THOMAS · 2013 to 2017
$2.1M
NIH HHS P51 OD011132NINDS NIH HHS P50 NS098685NINDS NIH HHS R01 NS083386
6 · The paper itself

Abstract

Over the last 10 years, the use of opto- and chemogenetics to modulate neuronal activity in research applications has increased exponentially. Both techniques involve the genetic delivery of artificial proteins (opsins or engineered receptors) that are expressed on a selective population of neurons. The firing of these neurons can then be manipulated using light sources (for opsins) or by systemic administration of exogenous compounds (for chemogenetic receptors). Opto- and chemogenetic tools have enabled many important advances in basal ganglia research in rodent models, yet these techniques have faced a slow progress in non-human primate (NHP) research. In this review, we present a summary of the current state of these techniques in NHP research and outline some of the main challenges associated with the use of these genetic-based approaches in monkeys. We also explore cutting-edge developments that will facilitate the use of opto- and chemogenetics in NHPs, and help advance our understanding of basal ganglia circuits in normal and pathological conditions.

Indexed as

OptogeneticsAnimalsBrainNeural PathwaysNeuronsPrimatesBasal gangliaChemogeneticsDREADDsMonkeysNon-human primatesOpsinsOptogenetics

Identifiers

PMID28238201
PMCPMC5572535
OpenAlexW2591571009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.